Study Title and Description
A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.|
|Author||Chadban SJ., Eris JM., Kanellis J., Pilmore H., Lee PC., Lim SK., Woodcock C., Kurstjens N., Russ G.|
|Country||Renal Medicine and Transplantation, Royal Prince Alfred Hospital and Sydney Medical School, Sydney, NSW, Australia.|
Pubmed ID: 24279685
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.